Analyst Estimates: Here's What Brokers Think Of CTEK AB (publ) (STO:CTEK) After Its Third-Quarter Report

As you might know, CTEK AB (publ) (STO:CTEK) recently reported its third-quarter numbers. It was a credible result overall, with revenues of kr213m and statutory earnings per share of kr0.21 both in line with analyst estimates, showing that CTEK is executing in line with expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Following the latest results, CTEK's three analysts are now forecasting revenues of kr961.8m in 2026. This would be a satisfactory 6.5% improvement in revenue compared to the last 12 months. Earnings are expected to improve, with CTEK forecast to report a statutory profit of kr1.12 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of kr995.2m and earnings per share (EPS) of kr1.21 in 2026. The analysts are less bullish than they were before these results, given the reduced revenue forecasts and the small dip in earnings per share expectations.

See our latest analysis for CTEK

Despite the cuts to forecast earnings, there was no real change to the kr21.33 price target, showing that the analysts don't think the changes have a meaningful impact on its intrinsic value. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic CTEK analyst has a price target of kr28.00 per share, while the most pessimistic values it at kr16.00. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await CTEK shareholders.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. It's clear from the latest estimates that CTEK's rate of growth is expected to accelerate meaningfully, with the forecast 5.2% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 1.5% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to see revenue growth of 8.3% annually. It seems obvious that, while the future growth outlook is brighter than the recent past, CTEK is expected to grow slower than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for CTEK going out to 2027, and you can see them free on our platform here.

And what about risks? Every company has them, and we've spotted 1 warning sign for CTEK you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.